Indications |
Subcutaneous Diabetes mellitus Adult: Dosing regimen should be individualised and adjusted based on patient's glycaemic response. Administer 15 min before or immediately after a meal. Renal impairment: Decreased dose may be necessary. Hepatic impairment: Decreased dose may be necessary. Special Populations: Renal impairment: CrCl 10-50 mL/min: 75% of normal dose; <10 mL/min: 25-50% of normal dose and monitor glucose closely. |
Contraindications |
Hypoglycaemia. |
Warnings / Precautions |
Renal or hepatic impairment; pregnancy, lactation; transferring from other insulin. Monitor serum glucose, potassium, electrolytes, HbA1c and lipid profile. Concomitant illness esp infections. |
Adverse Reactions |
Hypoglycaemia; oedema; pruritus; rash; hypersensitivity reactions; lipoatropy or lipohypertrophy with SC Inj (rotate Inj site). |
Drug Interactions |
Effects may be increased by: oral antidiabetic agents, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAOIs, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics. Effects may be decreased by: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents, isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, oral contraceptives, lithium. Signs of hypoglycaemia may be masked by β-blockers, clonidine. See Below for More insulin lispro Drug Interactions |
Mechanism of Actions |
Insulin lispro, a rapid-acting analog of human insulin, lowers blood glucose levels. It regulates carbohydrate, protein and fat metabolism by inhibiting hepatic glucose production and lipolysis, and enhancing peripheral glucose disposal. Onset: 15-30 min Duration: 3-6.5 hrs. |
Administration |
Should be taken with food. (Administer w/in 15 min before or immediately after meals.) |
ATC Classification |
A10AB04 - insulin lispro ; Belongs to the class of fast-acting insulins and analogues. Used in the treatment of diabetes. A10AC04 - insulin lispro ; Belongs to the class of intermediate-acting insulins and analogues. Used in the treatment of diabetes. A10AD04 - Insulin lispro ; Belongs to the class of intermediate-acting combined with fast-acting insulins and analogues. Used in the treatment of diabetes. |
Available As |
|
Insulin (Analogue) Lispro
Post Review about Insulin (Analogue) Lispro Click here to cancel reply.
Insulin (Analogue) Lispro Containing Brands
Insulin (Analogue) Lispro is used in following diseases
Drug - Drug Interactions of Insulin (Analogue) Lispro
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.